Publication | Closed Access

Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alpha

InflammationThrombosisPolycythemia VeraThrombopoiesisHematological MalignancyHematologyImmunologyPathologyDanish PatientsAutoimmunityRecombinant Interferon AlphaMedicineMyeloid Neoplasia